查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1504994

睡眠呼吸中止症用設備市場，佔有率，規模，趨勢，產業分析報告:各診斷設備，各治療設備，各終端用戶，各地區:各市場區隔預測，2024年～2032年

Sleep Apnea Devices Market Share, Size, Trends & Industry Analysis Report, By Diagnostic Devices; By Therapeutic Devices; By End User; By Region: Segment Forecast, 2024 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 116 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

根據 Polaris Market Research 的最新報告，到 2032 年，全球睡眠呼吸中止設備市場規模預計將達到 79.6 億美元，2024 年至 2032 年複合年增長率為 5.9%。 2023年，全球睡眠呼吸中止設備產業收入以PAP（氣道正壓通氣）為主。北美是2017年全球市場收入的主要貢獻者。

睡眠呼吸中止症是一種在睡眠期間呼吸過程中斷，導致大腦和身體缺氧的疾病。阻塞性睡眠呼吸中止症（OSA）是最常見的睡眠呼吸中止症類型，呼吸道阻塞是主要原因。其他睡眠呼吸中止症包括中樞性睡眠呼吸中止症和混合性睡眠呼吸中止症。為了避免此類疾病，必須對患者進行診斷測試並對適當的治療設備進行分類。睡眠呼吸中止症在老年人中更為常見。在許多情況下，由於疾病的非特異性表現和患者缺乏意識等因素，睡眠呼吸中止症仍未被診斷出來。

這種疾病的發生率不斷增加、個人反應能力不斷增強、老年人口不斷增長，以及對正確診斷和有效治療的需求不斷增長，是推動增長的一些關鍵因素。此外，提高舒適度和安全性的技術進步預計將增加該設備的利用率，特別是在北美等新興經濟體，這預計將成為市場發展的驅動力。

過去十年，睡眠呼吸中止症診斷產業經歷了快速成長。這一增長是由睡眠呼吸中止症設備的不斷進步所推動的。根據世界衛生組織 (WHO) 的報告，大約有 1 億人患有睡眠呼吸中止症。此外，阻塞性睡眠呼吸中止症是一種對健康產生負面影響的慢性疾病。根據國家健康睡眠意識計畫的報告，光在美國就有大約 2500 萬人受到這種疾病的影響。

睡眠呼吸中止症的發生會急劇增加其他疾病的風險，如糖代謝異常、憂鬱症、糖尿病、高血壓、全身性高血壓、心臟病和中風。所有這些疾病都會增加國家醫療保健總費用的負擔。人們對睡眠呼吸中止症的認識不斷提高以及睡眠呼吸中止症治療設備的廣泛使用預計將在不久的將來加速收入成長。

預計北美在 2017 年佔據最高的市場佔有率。如此大的市佔率主要是由於睡眠呼吸障礙（SDB）的高發生率。此外，人們越來越意識到新穎且技術先進的睡眠呼吸中止症設備正在推動北美市場的成長。

亞太市場預計將成為預測期內成長最快的產業。診所數量的增加和未確診患者數量的增加預計將在市場上形成利潤豐厚的成長機會。該地區的領先公司正致力於制定有利的政策，透過採用先進且具有成本效益的設備來擴大消費者基礎，預計這將在預測期內為市場提供強勁的成長機會。

睡眠呼吸中止症設備市場報告中介紹的一些知名公司包括 Fisher & Paykel Healthcare（紐西蘭）、Koninklijke Philips（荷蘭）、ResMed（美國）、Compumedics（澳洲）、Whole You（美國），其中包括 BMC Medical （中國）、Braebon Medical（加拿大）、Lowenstein Medical（德國）、Drive DeVilbiss Healthcare（美國）和SomnoMed（澳洲）。這些公司推出新產品，並與其他市場領導者合作，創新並推出新產品，以滿足消費者不斷增長的需求和需求。

目錄

第1章 概要與範圍

  • 調查目標和範圍
  • 調查的前提
  • 調查手法
    • 主要資料來源
    • 二次資料來源
  • 重要的要點
  • 利害關係者

第2章 執行概要

第3章 睡眠呼吸中止症用設備市場洞察

  • 睡眠呼吸中止症用設備-產業概要
  • 睡眠呼吸中止症用設備-生態系統分析
  • 睡眠呼吸中止症用設備市場動態
    • 睡眠呼吸中止症用設備-市場力量
      • 睡眠呼吸中止症用設備推動市場要素分析
      • 睡眠呼吸中止症用設備阻礙市場要素/課題分析
      • 睡眠呼吸中止症用設備市場機會分析
  • 產業分析-波特的五力分析
    • 供應商談判力
    • 買方議價能力
    • 替代品的威脅
    • 新加入廠商的威脅
    • 競爭的程度
  • 睡眠呼吸中止症用設備市場PEST分析
  • 睡眠呼吸中止症用設備市場價值鏈分析
  • 睡眠呼吸中止症用設備產業趨勢
  • 競爭排行榜分析，2017年

第4章 睡眠呼吸中止症用設備市場規模與預測，2018～2026年，各診斷設備

  • 主要調查結果
  • 多導睡眠圖設備 (PSG)
  • 呼吸測謊儀
  • 脈搏血氧計
  • 體動記錄儀

第5章 睡眠呼吸中止症用設備市場規模與預測，2018～2026年，各治療設備

  • 主要調查結果
  • 正壓呼吸器(PAP)設備
  • 氧氣設備
  • 口腔設備
  • 自適應伺服通風(ASV)設備

第6章 睡眠呼吸中止症用設備市場規模與預測，2018～2026年，各終端用戶

  • 主要調查結果
  • 與醫院睡眠研究所
  • 居家照護

第7章 睡眠呼吸中止症用設備市場規模與預測，2018～2026年，各地區

  • 主要調查結果
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 比利時
    • 俄羅斯
    • 荷蘭
    • 其他的歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 新加坡
    • 馬來西亞
    • 印尼
    • 泰國
    • 菲律賓
    • 其他的亞太地區
  • 南美
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他的南美
  • 中東·非洲
    • 阿拉伯聯合大公國
    • 沙烏地阿拉伯
    • 南非
    • 其他的中東·非洲

第8章 企業簡介

  • Fisher & Paykel Healthcare(紐西蘭)
  • Koninklijke Philips(荷蘭)
  • ResMed(美國)
  • Compumedics(澳洲)
  • Whole You(美國)
  • BMC Medical(中國)
  • Braebon Medical(加拿大)
  • Lowenstein Medical(德國)
  • Drive DeVilbiss Healthcare(美國)
  • SomnoMed(澳洲)
簡介目錄
Product Code: PM1597

The global sleep apnea devices market size is anticipated to reach USD 7.96 billion by 2032 growing at a CAGR of 5.9% from 2024 to 2032 according to a new report published by Polaris Market Research. The report 'Sleep Apnea Devices Market Share, Size, Trends & Industry Analysis Report, By Diagnostic Devices (PSG, Respiratory polygraphs, Pulse Oximeters, Actigraphy Devices); By Therapeutic Devices (PAP, Oxygen Devices, Oral Appliances); By End User; By Region: Segment Forecast, 2024 - 2032' provides insights on the current market scenario and the future prospects. In 2023, the Positive airway pressure (PAP) dominated the global Sleep Apnea Devices industry, in terms of revenue. North America was to be the leading contributor to the global market revenue in 2017.

Sleep apnea is an ailment which befalls when the brain as well as body obtain inadequate amount of oxygen where breathing process is interfered while sleeping. Obstructive Sleep Apnea (OSA) is the most common type of sleep apnea which is majorly triggered by airway blockage. Other forms of sleep apnea are central sleep apnea, and complex sleep apnea syndrome. In order to avoid such disease, it is essential to perform diagnostic tests on the patient to classify the appropriate therapeutic devices for treatment. Sleep apnea is extensively observed in the elderly population. There are multiple instances where sleep apnea is kept un-diagnosed due to factors such as non-specific exhibition of the disorder and lack of awareness amongst the patients.

Growing frequency of this disease along with the increasing need for appropriate diagnosis and effective treatment, increasing responsiveness among individuals, and growing geriatric population are some of the major factors encouraging the industry growth. Moreover, technological advancements augmenting comfort and safety is expected to enhance the usage of device rates especially in developed economies such as North America, which in turn is estimated to drive the market growth.

The sleep apnea diagnosis industry has witnessed rapid surge during the past decade. The growth is been attributed to the continuous development in sleep apnea device usage. According to the World Health Organization (WHO) reports, about 100 million individuals are suffering from sleep apnea. In addition, obstructive sleep apnea and is a chronic disease that unfavorably affects health. According to the National Healthy Sleep Awareness Project reports, around 25 million people are affected by this disease alone in the U.S.

Occurrence of sleep apnea surges the risk of other ailments such as abnormal glucose metabolism, depression, diabetes, high blood pressure, systemic hypertension, heart disease, and strokes. This all disorders further rises the total healthcare cost weight on the nation. Increasing consciousness regarding the sleep apnea along with welfare of using sleep apnea devices are anticipated to upsurge the revenue growth during the near future.

The North America was estimated to hold the highest market share during 2017. The large market share is majorly attributed to due to the high occurrence of Sleep-Disordered Breathing (SDB). Moreover, there is also a growing awareness amongst the for the novel and technologically advanced sleep apnea devices that are driving the growth of market growth in North America.

Asia Pacific market is anticipated to be the fastest growing industry during the forecast period. Growing number of clinics and large number of undiagnosed patient pool are expected to form lucrative growth opportunity in the market. Key players present in this region are focusing on constructing favorable policies towards enhancing the consumer pool through introduction of advanced as and cost-effective devices which in turn is expected to provide robust growth opportunities in the market during the forecast period.

The well-known companies profiled in the Sleep Apnea Devices market report include Fisher & Paykel Healthcare (New Zealand), Koninklijke Philips (Netherlands), ResMed (US), Compumedics (Australia), Whole You (US), BMC Medical (China), Braebon Medical (Canada), Lowenstein Medical (Germany), Drive DeVilbiss Healthcare (US), and SomnoMed (Australia). These companies launch new products and collaborate with other leaders in the market to innovate and launch new products to meet the increasing needs and requirements of consumers.

Polaris Market Research has segmented the global Sleep Apnea Devices market on the basis of diagnostic devices, therapeutic devices, end user, and region:

Sleep Apnea Devices, Devices Outlook (Revenue, USD Billion, 2015 - 2026)

  • Diagnostics Devices
  • Polysomnography Devices (PSG)
  • Respiratory polygraphs
  • Pulse Oximeters
  • Actigraphy Devices
  • Therapeutics Devices
  • Positive Airway Pressure (PAP) Devices
  • Oxygen Devices
  • Oral Appliances
  • Adaptive Servo Ventilation (ASV) Devices

Sleep Apnea Devices, End User Outlook (Revenue, USD Billion, 2015 - 2026)

  • Hospitals & Sleep Laboratories
  • Home care settings

Sleep Apnea Devices, Regional Outlook (Revenue, USD Billion, 2015 - 2026)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Belgium
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia-Pacific
  • China
  • India
  • Japan
  • Korea
  • Singapore
  • Malaysia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of Asia-Pacific
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • South Africa
  • Rest of MEA

Table of Contents

1. Overview and Scope

  • 1.1. Research goal & scope
  • 1.2. Research assumptions
  • 1.3. Research Methodology
    • 1.3.1. Primary data sources
    • 1.3.2. Secondary data sources
  • 1.4. Key take-away
  • 1.5. Stakeholders

2. Executive Summary

  • 2.1. Market Definition
  • 2.2. Market Segmentation

3. Sleep Apnea Devices Market Insights

  • 3.1. Sleep Apnea Devices - Industry snapshot
  • 3.2. Sleep Apnea Devices - Ecosystem analysis
  • 3.3. Sleep Apnea Devices Market Dynamics
    • 3.3.1. Sleep Apnea Devices - Market Forces
      • 3.3.1.1. Sleep Apnea Devices Market Driver Analysis
      • 3.3.1.2. Sleep Apnea Devices Market Restraint/Challenges analysis
      • 3.3.1.3. Sleep Apnea Devices Market Opportunity Analysis
  • 3.4. Industry analysis - Porter's five force
    • 3.4.1. Bargaining power of supplier
    • 3.4.2. Bargaining power of buyer
    • 3.4.3. Threat of substitute
    • 3.4.4. Threat of new entrant
    • 3.4.5. Degree of competition
  • 3.5. Sleep Apnea Devices Market PEST Analysis
  • 3.6. Sleep Apnea Devices Market Value Chain Analysis
  • 3.7. Sleep Apnea Devices Industry Trends
  • 3.8. Competitive Ranking Analysis, 2017

4. Sleep Apnea Devices Market Size and Forecast, 2018-2026 by Diagnostic Devices

  • 4.1. Key Findings
  • 4.2. Polysomnography Devices (PSG)
  • 4.3. Respiratory polygraphs
  • 4.4. Pulse Oximeters
  • 4.5. Actigraphy Devices

5. Sleep Apnea Devices Market Size and Forecast, 2018-2026 by Therapeutic Devices

  • 5.1. Key Findings
  • 5.2. Positive Airway Pressure (PAP) Devices
  • 5.3. Oxygen Devices
  • 5.4. Oral Appliances
  • 5.5. Adaptive Servo Ventilation (ASV) Devices

6. Sleep Apnea Devices Market Size and Forecast, 2018-2026 by End User

  • 6.1. Key Findings
  • 6.2. Hospitals & Sleep Laboratories
  • 6.3. Home care settings

7. Sleep Apnea Devices Market Size and Forecast, 2018-2026 by Region

  • 7.1. Key Findings
  • 7.2. North America
    • 7.2.1. U.S.
    • 7.2.2. Canada
  • 7.3. Europe
    • 7.3.1. Germany
    • 7.3.2. UK
    • 7.3.3. France
    • 7.3.4. Italy
    • 7.3.5. Spain
    • 7.3.6. Belgium
    • 7.3.7. Russia
    • 7.3.8. Netherlands
    • 7.3.9. Rest of Europe
  • 7.4. Asia-Pacific
    • 7.4.1. China
    • 7.4.2. India
    • 7.4.3. Japan
    • 7.4.4. Korea
    • 7.4.5. Singapore
    • 7.4.6. Malaysia
    • 7.4.7. Indonesia
    • 7.4.8. Thailand
    • 7.4.9. Philippines
    • 7.4.10. Rest of Asia-Pacific
  • 7.5. Latin America
    • 7.5.1. Brazil
    • 7.5.2. Mexico
    • 7.5.3. Argentina
    • 7.5.4. Rest of LATAM
  • 7.6. Middle East & Africa
    • 7.6.1. UAE
    • 7.6.2. Saudi Arabia
    • 7.6.3. South Africa
    • 7.6.4. Rest of MEA

8. Company Profiles

  • 8.1. Fisher & Paykel Healthcare (New Zealand)
    • 8.1.1. Overview
    • 8.1.2. Financials
    • 8.1.3. Product Benchmarking
    • 8.1.4. Recent Developments
  • 8.2. Koninklijke Philips (Netherlands)
    • 8.2.1. Overview
    • 8.2.2. Financials
    • 8.2.3. Product Benchmarking
    • 8.2.4. Recent Developments
  • 8.3. ResMed (U.S.)
    • 8.3.1. Overview
    • 8.3.2. Financials
    • 8.3.3. Product Benchmarking
    • 8.3.4. Recent Developments
  • 8.4. Compumedics (Australia)
    • 8.4.1. Overview
    • 8.4.2. Financials
    • 8.4.3. Product Benchmarking
    • 8.4.4. Recent Developments
  • 8.5. Whole You (U.S.)
    • 8.5.1. Overview
    • 8.5.2. Financials
    • 8.5.3. Product Benchmarking
    • 8.5.4. Recent Developments
  • 8.6. BMC Medical (China)
    • 8.6.1. Overview
    • 8.6.2. Financials
    • 8.6.3. Product Benchmarking
    • 8.6.4. Recent Developments
  • 8.7. Braebon Medical (Canada)
    • 8.7.1. Overview
    • 8.7.2. Financials
    • 8.7.3. Product Benchmarking
    • 8.7.4. Recent Developments
  • 8.8. Lowenstein Medical (Germany)
    • 8.8.1. Overview
    • 8.8.2. Financials
    • 8.8.3. Product Benchmarking
    • 8.8.4. Recent Developments
  • 8.9. Drive DeVilbiss Healthcare (U.S.)
    • 8.9.1. Overview
    • 8.9.2. Financials
    • 8.9.3. Product Benchmarking
    • 8.9.4. Recent Developments
  • 8.10. SomnoMed (Australia)
    • 8.10.1. Overview
    • 8.10.2. Financials
    • 8.10.3. Product Benchmarking
    • 8.10.4. Recent Developments